Nureca Limited , a prominent player in the home healthcare and wellness sector, has received a significant regulatory green light from the Securities and Exchange Board of India (SEBI). The company announced that SEBI has granted approval for an exemption from Regulation 24(ii) of the Buy-Back Regulations, allowing Nureca to proceed with a share buyback while its merger scheme with wholly-owned subsidiary Nureca Technologies Private Limited is pending before the National Company Law Tribunal (NCLT).

Key Developments

• SEBI Approval: Granted
• Merger Scheme Approval: Board approved on May 20; Shareholders approved on June 16
• Merger Type: Internal restructuring involving no new equity issuance or change in shareholding pattern
• Buyback Participation: Promoters have committed not to participate, making it exclusive for public shareholders

Regulatory Context

The exemption granted by SEBI is from Regulation 24(ii) of the SEBI (Buy-Back of Securities) Regulations, 2018, which typically prohibits companies from announcing buybacks during pending schemes of arrangement. SEBI's decision to grant this exemption considers the nature of the merger as an internal restructuring that does not affect the company's public shareholding.

Implications for Shareholders

This development is particularly significant for Nureca's public shareholders. With the promoters abstaining from the buyback, the opportunity is exclusively available to public shareholders, potentially offering them an avenue to realize value in the near term.

Next Steps

Nureca's board of directors will consider the buyback proposal at an appropriate time. The company has assured compliance with all applicable regulations throughout the process.

Market Perspective

This move by Nureca Limited demonstrates a strategic approach to capital management while navigating regulatory requirements. The ability to proceed with a share buyback during a pending merger reflects the company's focus on shareholder value and its confidence in its financial position.

As the home healthcare and wellness sector continues to evolve, Nureca's actions may be indicative of broader trends in corporate strategy within the industry, balancing growth initiatives with shareholder returns.

Investors are advised to monitor further announcements from Nureca Limited regarding the specifics of the buyback program and the progress of the merger with Nureca Technologies Private Limited.

Nureca Limited , a prominent player in the home healthcare and wellness products sector, has released its financial results for the second quarter and half-year ended September 30, 2025, revealing a strong performance with significant growth in revenue and profitability.

Financial Performance

The company's unaudited consolidated financial results for Q2 FY2026 show:

Nureca Limited demonstrated robust growth in its quarterly performance. The company's revenue increased by 21% year-over-year, reaching ₹37.70 crore in Q2 FY2026 compared to ₹31.20 crore in Q2 FY2025. For the first half of FY2026, revenue showed an impressive 40% growth, reaching ₹71.90 crore compared to ₹51.50 crore in H1 FY2025.

The company's profitability saw a significant turnaround. Operating profits surged by 237.50% year-over-year to ₹3.30 crore, compared to a loss of ₹2.40 crore in the same quarter last year. Net profit after tax increased substantially to ₹3.60 crore from a loss of ₹0.50 crore in Q2 FY2025.

Key Factors Contributing to Performance

Nureca attributed its strong performance to several factors:

1. Focused Cost Optimization: The company's efforts in streamlining operations and reducing costs have contributed to the improved profitability.

2. Growth in Quick Commerce Sales Channels: The expansion and success in quick commerce channels have driven revenue growth.

3. Digital-First Approach: Nureca operates as a digital-first healthcare company, with over 93% of its revenue generated through online sales.

4. Asset-Light Business Model: The company maintains a debt-free, asset-light business model, which contributes to its financial flexibility and efficiency.

Business Model and Strategy

Nureca's business model is characterized by its strong focus on digital channels and asset-light operations:

1. Digital-First Strategy: With more than 93% of revenue coming from online sales, Nureca has successfully leveraged e-commerce platforms to reach its customers.

2. Debt-Free Operations: The company's debt-free status provides financial stability and reduces interest expenses.

3. Asset-Light Model: This approach allows for greater flexibility and potentially higher returns on invested capital.

Market Outlook

The home healthcare and wellness products sector continues to show strong growth potential, driven by increasing health consciousness and the convenience of home-based care solutions. Nureca's digital-first approach and focus on quick commerce channels position it well to capitalize on these trends.

Conclusion

Nureca Limited's Q2 FY2026 results demonstrate the company's ability to drive significant revenue growth and achieve profitability in a competitive market. The substantial improvements in both top-line and bottom-line figures underscore the effectiveness of the company's strategies, particularly its digital-first approach and focus on cost optimization.

As Nureca continues to expand its presence in the quick commerce space and maintain its asset-light, debt-free model, the company's ability to sustain this growth trajectory and further improve its market position in the home healthcare and wellness products industry will be closely watched by investors and market observers.